期刊文献+

反相高效液相色谱法同时测定散利痛片3组分的血药浓度 被引量:3

Simultaneous Determination of Three Components of Saridon Tablet in Human Plasma by RP-HPLC
下载PDF
导出
摘要 目的建立以反相高效液相色谱法同时测定散利痛片中咖啡因、对乙酰氨基酚、异丙基安替比林3组分血药浓度的方法。方法色谱柱为HypersilHypurityTMAdvance,流动相为0.01mol/L磷酸-甲醇-四氢呋喃(86∶12∶2),检测波长为273nm。结果3组分检测浓度线性范围分别为0.39~100.0、1.96~500.0、1.17~300.0μg/ml,准确度均大于95.0%,日内、日间RSD均小于10.0%。结论该方法灵敏、准确、快速,特异性好,能满足散利痛3组分血药浓度测定要求。 OBJECTIVE:To establish a RP-HPLC method for simultaneous determination of caffine,acetaminophen and isopropylphenazone in human plasma after oral dose of saridon.METHODS:Hypersil Hypurity TM Advance was used as chromatographic column and the mobile phase was a mixture of0.01mol/L phosphoric acid-methanol-tetrahydrofuran(86∶12∶2).The detection wavelength was273nm.RESULTS:The calibration curves were linear in the ranges of0.39~100.0μg/ml for caffine,1.96~500.0μg/ml for acetaminophen,and1.17~300.0μg/ml for iso...
出处 《中国药房》 CAS CSCD 北大核心 2006年第18期1395-1397,共3页 China Pharmacy
关键词 散利痛 咖啡因 对乙酰氨基酚 异丙基安替比林 高效液相色谱法 血药浓度 Saridon Caffine Acetaminophen Isopropylphenazone HPLC Blood drug concentration
  • 相关文献

参考文献5

二级参考文献19

  • 1蒋惠留.癌症疼痛的评价与治疗[J].中国肿瘤临床,1995,22(7):507-509. 被引量:36
  • 2许真之,陈桂良.对乙酰氨基酚溶液的HPLC测定[J].中国医药工业杂志,1996,27(7):313-315. 被引量:3
  • 3单宝珠,王永铭.小儿用扑热息痛滴剂的相对生物利用度[J].上海医科大学学报,1996,23(6):461-463. 被引量:3
  • 4彭文兴,闫小华,李焕德,蔡卓夫,刘芳群.对乙酰氨基酚凝胶在人体的药动学和生物利用度[J].中国医院药学杂志,1997,17(2):56-58. 被引量:11
  • 5Ou - yang DS,Huang SL,Xie HG,et al. Use of caffeine as a probe forrapid determination of cytochrome P -450 CYP1 A2 activity in humans. Acta Pharmacol Sin, 1995,19:44.
  • 6Tang BK, Kalow W. Assays for CYP1 A2 by testing in vivo metabolism of caffeine in humans. Methods Enzymol, 1996,272:124.
  • 7Mandema JW, Tuk B, van Steveninck AL, et al. Pharmacokinetic -pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha - hydroxymidazolam in healthy volunteers. Clin Pharmacol Ther , 1992,51:715.
  • 8Streetman DS, Bertino JS Jr, Nafziger AN. Phenotyping of drug - metabolizing enzymes in adults : a review of in - vivo cytochrome P450 phenotyping probes. Pharmacogenetics ,2000,10 : 187.
  • 9Dierks EA,Stams KR, Lim HK,et al. A method for the simultaneous evaluation of the activities of seven major human drug - metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry. Drug Metab Dispos ,2001,29:23.
  • 10Carrillo JA, Ramos SI, Agundez JA, et al. Analysis of midazolam and metabolites in plasma by high - performance liquid chromatography:probe of CYP3 A. Ther Drug Monit , 1998,20:319.

共引文献59

同被引文献20

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部